174 related articles for article (PubMed ID: 19853756)
1. Body wall and visceral nonrhabdomyosarcoma soft tissue sarcomas in children and adolescents.
Navid F; Billups CA; Krasin MJ; Davidoff AM; Harper J; Rao BN; Spunt SL
J Pediatr Surg; 2009 Oct; 44(10):1965-71. PubMed ID: 19853756
[TBL] [Abstract][Full Text] [Related]
2. Pediatric nonrhabdomyosarcoma soft tissue sarcomas arising at visceral sites.
Ferrari A; Magni C; Bergamaschi L; Cecchetto G; Alaggio R; Milano GM; Bertolini P; Basso E; Manzitti C; Di Martino M; Giurici N; Melchionda F; Cecinati V; Chiaravalli S; Affinita MC; Scagnellato A; Casanova M; Bisogno G
Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28233470
[TBL] [Abstract][Full Text] [Related]
3. An approach for cure: PEI-chemotherapy and regional deep hyperthermia in children and adolescents with unresectable malignant tumors.
Wessalowski R; Schneider DT; Mils O; Hannen M; Calaminus G; Engelbrecht V; Pape H; Willers R; Engert J; Harms D; Göbel U
Klin Padiatr; 2003; 215(6):303-9. PubMed ID: 14677093
[TBL] [Abstract][Full Text] [Related]
4. Paediatric non-rhabdomyosarcoma soft tissue sarcomas: the prospective NRSTS 2005 study by the European Pediatric Soft Tissue Sarcoma Study Group (EpSSG).
Ferrari A; van Noesel MM; Brennan B; Zanetti I; Corradini N; Casanova M; Berlanga P; Merks JHM; Alaggio R; Schifflers S; Ramirez-Villar GL; Giraudo C; Burrieza GG; Safwat A; Bisogno G; De Salvo GL; Orbach D
Lancet Child Adolesc Health; 2021 Aug; 5(8):546-558. PubMed ID: 34214481
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for children and adolescents with surgically resected nonrhabdomyosarcoma soft tissue sarcoma: an analysis of 121 patients treated at St Jude Children's Research Hospital.
Spunt SL; Poquette CA; Hurt YS; Cain AM; Rao BN; Merchant TE; Jenkins JJ; Santana VM; Pratt CB; Pappo AS
J Clin Oncol; 1999 Dec; 17(12):3697-705. PubMed ID: 10577841
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant chemotherapy for the treatment of advanced pediatric nonrhabdomyosarcoma soft tissue sarcoma: the National Cancer Institute experience.
Nathan PC; Tsokos M; Long L; Bernstein D; Wexler LH; Mackall CL; Helman LJ
Pediatr Blood Cancer; 2005 May; 44(5):449-54. PubMed ID: 15547929
[TBL] [Abstract][Full Text] [Related]
7. The role of adjuvant chemotherapy in children and adolescents with surgically resected, high-risk adult-type soft tissue sarcomas.
Ferrari A; Brecht IB; Koscielniak E; Casanova M; Scagnellato A; Bisogno G; Alaggio R; Cecchetto G; Catania S; Meazza C; Int-Veen C; Kirsch S; Dantonello T; Carli M; Treuner J
Pediatr Blood Cancer; 2005 Aug; 45(2):128-34. PubMed ID: 15852434
[TBL] [Abstract][Full Text] [Related]
8. Treatment of unresectable or metastatic pediatric soft tissue sarcomas with surgery, irradiation, and chemotherapy: a Pediatric Oncology Group study.
Pratt CB; Maurer HM; Gieser P; Salzberg A; Rao BN; Parham D; Thomas PR; Marcus RB; Cantor A; Pick T; Green D; Neff J; Jenkins JJ
Med Pediatr Oncol; 1998 Apr; 30(4):201-9. PubMed ID: 9473754
[TBL] [Abstract][Full Text] [Related]
9. Therapy for childhood soft-tissue sarcomas other than rhabdomyosarcoma: a review of 62 cases treated at a single institution.
Horowitz ME; Pratt CB; Webber BL; Hustu HO; Etcubanas E; Miliauskas J; Rao BN; Fleming ID; Mahesh Kumar AP; Green AA
J Clin Oncol; 1986 Apr; 4(4):559-64. PubMed ID: 3514805
[TBL] [Abstract][Full Text] [Related]
10. Failure patterns and survival in pediatric soft tissue sarcoma.
Brizel DM; Weinstein H; Hunt M; Tarbell NJ
Int J Radiat Oncol Biol Phys; 1988 Jul; 15(1):37-41. PubMed ID: 3391826
[TBL] [Abstract][Full Text] [Related]
11. Clinical features and outcome of initially unresected nonmetastatic pediatric nonrhabdomyosarcoma soft tissue sarcoma.
Spunt SL; Hill DA; Motosue AM; Billups CA; Cain AM; Rao BN; Pratt CB; Merchant TE; Pappo AS
J Clin Oncol; 2002 Aug; 20(15):3225-35. PubMed ID: 12149295
[TBL] [Abstract][Full Text] [Related]
12. Is reexcision in pediatric nonrhabdomyosarcoma soft tissue sarcoma necessary after an initial unplanned resection?
Chui CH; Spunt SL; Liu T; Pappo AS; Davidoff AM; Rao BN; Shochat SJ
J Pediatr Surg; 2002 Oct; 37(10):1424-9. PubMed ID: 12378447
[TBL] [Abstract][Full Text] [Related]
13. Long-term results of a phase 2 study of neoadjuvant chemotherapy and radiotherapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation Therapy Oncology Group Trial 9514.
Kraybill WG; Harris J; Spiro IJ; Ettinger DS; DeLaney TF; Blum RH; Lucas DR; Harmon DC; Letson GD; Eisenberg B
Cancer; 2010 Oct; 116(19):4613-21. PubMed ID: 20572040
[TBL] [Abstract][Full Text] [Related]
14. The value of postoperative radiotherapy in childhood nonrhabdomyosarcoma soft tissue sarcoma.
Paulino AC; Ritchie J; Wen BC
Pediatr Blood Cancer; 2004 Oct; 43(5):587-93. PubMed ID: 15382277
[TBL] [Abstract][Full Text] [Related]
15. Clinical features and outcomes of young patients with epithelioid sarcoma: an analysis from the Children's Oncology Group and the European paediatric soft tissue Sarcoma Study Group prospective clinical trials.
Spunt SL; Francotte N; De Salvo GL; Chi YY; Zanetti I; Hayes-Jordan A; Kao SC; Orbach D; Brennan B; Weiss AR; van Noesel MM; Million L; Alaggio R; Parham DM; Kelsey A; Randall RL; McCarville MB; Bisogno G; Hawkins DS; Ferrari A
Eur J Cancer; 2019 May; 112():98-106. PubMed ID: 30954717
[TBL] [Abstract][Full Text] [Related]
16. Outcome of extracranial malignant rhabdoid tumours in children registered in the European Paediatric Soft Tissue Sarcoma Study Group Non-Rhabdomyosarcoma Soft Tissue Sarcoma 2005 Study-EpSSG NRSTS 2005.
Brennan B; De Salvo GL; Orbach D; De Paoli A; Kelsey A; Mudry P; Francotte N; Van Noesel M; Bisogno G; Casanova M; Ferrari A
Eur J Cancer; 2016 Jun; 60():69-82. PubMed ID: 27082136
[TBL] [Abstract][Full Text] [Related]
17. Open-label, multicentre, randomised, phase II study of the EpSSG and the ITCC evaluating the addition of bevacizumab to chemotherapy in childhood and adolescent patients with metastatic soft tissue sarcoma (the BERNIE study).
Chisholm JC; Merks JHM; Casanova M; Bisogno G; Orbach D; Gentet JC; Thomassin-Defachelles AS; Chastagner P; Lowis S; Ronghe M; McHugh K; van Rijn RR; Hilton M; Bachir J; Fürst-Recktenwald S; Geoerger B; Oberlin O;
Eur J Cancer; 2017 Sep; 83():177-184. PubMed ID: 28738258
[TBL] [Abstract][Full Text] [Related]
18. Nonrhabdomyosarcoma soft tissue sarcoma (NRSTS) in pediatric and young adult patients: Results from a prospective study using limited-margin radiotherapy.
Tinkle CL; Fernandez-Pineda I; Sykes A; Lu Z; Hua CH; Neel MD; Bahrami A; Shulkin BL; Kaste SC; Pappo A; Spunt SL; Krasin MJ
Cancer; 2017 Nov; 123(22):4419-4429. PubMed ID: 28759114
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of neoadjuvant vincristine, ifosfamide, and doxorubicin with granulocyte colony-stimulating factor support in children and adolescents with advanced-stage nonrhabdomyosarcomatous soft tissue sarcomas: a Pediatric Oncology Group Study.
Pappo AS; Devidas M; Jenkins J; Rao B; Marcus R; Thomas P; Gebhardt M; Pratt C; Grier HE
J Clin Oncol; 2005 Jun; 23(18):4031-8. PubMed ID: 15767644
[TBL] [Abstract][Full Text] [Related]
20. Clinical features and outcomes of infantile soft-tissue sarcoma: A multicenter retrospective study in Beijing.
Zhu S; Xu N; Zhi T; Gao Y; Zhong D; Zhang W; Jin M; Sun Q; Xie Y; Zhang X; Li L; Wang S; Wang H; Liu R; Zhao W; Huang D; Ni X; Ma X
J Cancer Res Ther; 2023 Aug; 19(4):876-880. PubMed ID: 37675711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
